US Stock MarketDetailed Quotes

Vivani Medical (VANI)

Watchlist
  • 1.040
  • 0.0000.00%
Close Apr 10 16:00 ET
  • 1.040
  • 0.0000.00%
Post 20:01 ET
88.03MMarket Cap-2.42P/E (TTM)

Vivani Medical (VANI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.67%27.56M
5.42%6.81M
6.59%6.73M
31.35%7.46M
5.30%6.56M
-8.49%24.68M
3.91%6.46M
-11.69%6.31M
-18.88%5.68M
-5.67%6.23M
Selling and administrative expenses
5.58%9.43M
1.07%2.18M
4.75%2.21M
24.68%2.7M
-6.44%2.34M
-10.65%8.93M
42.94%2.16M
-22.09%2.11M
-30.93%2.17M
-5.48%2.5M
-General and administrative expense
5.58%9.43M
1.07%2.18M
4.75%2.21M
24.68%2.7M
-6.44%2.34M
-10.65%8.93M
42.94%2.16M
-22.09%2.11M
-30.93%2.17M
-5.48%2.5M
Research and development costs
15.12%18.13M
7.60%4.63M
7.52%4.52M
35.47%4.76M
13.18%4.22M
-7.21%15.75M
-8.60%4.3M
-5.36%4.2M
-9.08%3.51M
-5.79%3.73M
Operating profit
-11.67%-27.56M
-5.42%-6.81M
-6.59%-6.73M
-31.35%-7.46M
-5.30%-6.56M
8.49%-24.68M
-3.91%-6.46M
11.69%-6.31M
18.88%-5.68M
5.67%-6.23M
Net non-operating interest income expense
Other net income (expense)
-20.49%947K
-56.83%177K
-27.24%195K
-2.15%318K
35.64%255K
-9.29%1.19M
114.66%410K
-25.97%268K
-31.87%325K
-33.57%188K
Other non- operating income (expenses)
-20.49%947K
-56.83%177K
-27.24%195K
-2.15%318K
35.64%255K
-9.29%1.19M
114.66%410K
-25.97%268K
-31.87%325K
-33.57%188K
Income before tax
-13.30%-26.61M
-9.64%-6.63M
-8.09%-6.53M
-33.38%-7.14M
-4.36%-6.3M
8.44%-23.49M
-0.40%-6.05M
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
Income tax
Net income
-13.30%-26.61M
-9.64%-6.63M
-8.09%-6.53M
-33.38%-7.14M
-4.36%-6.3M
8.44%-23.49M
-0.40%-6.05M
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
Net income continuous Operations
-13.30%-26.61M
-9.64%-6.63M
-8.09%-6.53M
-33.38%-7.14M
-4.36%-6.3M
8.44%-23.49M
-0.40%-6.05M
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
Minority interest income
Net income attributable to the parent company
-13.30%-26.61M
-9.64%-6.63M
-8.09%-6.53M
-33.38%-7.14M
-4.36%-6.3M
8.44%-23.49M
-0.40%-6.05M
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-13.30%-26.61M
-9.64%-6.63M
-8.09%-6.53M
-33.38%-7.14M
-4.36%-6.3M
8.44%-23.49M
-0.40%-6.05M
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
Basic earnings per share
0.00%-0.43
18.18%-0.09
0.00%-0.11
-20.00%-0.12
8.33%-0.11
14.00%-0.43
0.00%-0.11
15.38%-0.11
23.08%-0.1
0.00%-0.12
Diluted earnings per share
0.00%-0.43
18.18%-0.09
0.00%-0.11
-20.00%-0.12
8.33%-0.11
14.00%-0.43
0.00%-0.11
15.38%-0.11
23.08%-0.1
0.00%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.67%27.56M5.42%6.81M6.59%6.73M31.35%7.46M5.30%6.56M-8.49%24.68M3.91%6.46M-11.69%6.31M-18.88%5.68M-5.67%6.23M
Selling and administrative expenses 5.58%9.43M1.07%2.18M4.75%2.21M24.68%2.7M-6.44%2.34M-10.65%8.93M42.94%2.16M-22.09%2.11M-30.93%2.17M-5.48%2.5M
-General and administrative expense 5.58%9.43M1.07%2.18M4.75%2.21M24.68%2.7M-6.44%2.34M-10.65%8.93M42.94%2.16M-22.09%2.11M-30.93%2.17M-5.48%2.5M
Research and development costs 15.12%18.13M7.60%4.63M7.52%4.52M35.47%4.76M13.18%4.22M-7.21%15.75M-8.60%4.3M-5.36%4.2M-9.08%3.51M-5.79%3.73M
Operating profit -11.67%-27.56M-5.42%-6.81M-6.59%-6.73M-31.35%-7.46M-5.30%-6.56M8.49%-24.68M-3.91%-6.46M11.69%-6.31M18.88%-5.68M5.67%-6.23M
Net non-operating interest income expense
Other net income (expense) -20.49%947K-56.83%177K-27.24%195K-2.15%318K35.64%255K-9.29%1.19M114.66%410K-25.97%268K-31.87%325K-33.57%188K
Other non- operating income (expenses) -20.49%947K-56.83%177K-27.24%195K-2.15%318K35.64%255K-9.29%1.19M114.66%410K-25.97%268K-31.87%325K-33.57%188K
Income before tax -13.30%-26.61M-9.64%-6.63M-8.09%-6.53M-33.38%-7.14M-4.36%-6.3M8.44%-23.49M-0.40%-6.05M10.93%-6.04M17.93%-5.36M4.42%-6.04M
Income tax
Net income -13.30%-26.61M-9.64%-6.63M-8.09%-6.53M-33.38%-7.14M-4.36%-6.3M8.44%-23.49M-0.40%-6.05M10.93%-6.04M17.93%-5.36M4.42%-6.04M
Net income continuous Operations -13.30%-26.61M-9.64%-6.63M-8.09%-6.53M-33.38%-7.14M-4.36%-6.3M8.44%-23.49M-0.40%-6.05M10.93%-6.04M17.93%-5.36M4.42%-6.04M
Minority interest income
Net income attributable to the parent company -13.30%-26.61M-9.64%-6.63M-8.09%-6.53M-33.38%-7.14M-4.36%-6.3M8.44%-23.49M-0.40%-6.05M10.93%-6.04M17.93%-5.36M4.42%-6.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -13.30%-26.61M-9.64%-6.63M-8.09%-6.53M-33.38%-7.14M-4.36%-6.3M8.44%-23.49M-0.40%-6.05M10.93%-6.04M17.93%-5.36M4.42%-6.04M
Basic earnings per share 0.00%-0.4318.18%-0.090.00%-0.11-20.00%-0.128.33%-0.1114.00%-0.430.00%-0.1115.38%-0.1123.08%-0.10.00%-0.12
Diluted earnings per share 0.00%-0.4318.18%-0.090.00%-0.11-20.00%-0.128.33%-0.1114.00%-0.430.00%-0.1115.38%-0.1123.08%-0.10.00%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More